Prospective Cohort Study Evaluating the Prognosis of Patients with Resectable Large 3 and 4 Type Gastric Cancer and Clinical Phase II trial Evaluating the Safety and Benefit of Perioperative Chemotherapy for Resectable Large 3 and 4 Type Gastric Cancer
Phase 2
Recruiting
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000013491
- Lead Sponsor
- Department of Surgical Oncology, Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. administration contraindication of TS-1, CDDP, DOC, PAC 2. severe complications such as paralytic ileus, bowel obstruction, interstitial pneumonitis or pulmonary fibrosis, uncontrolled diabetes mellitus, heart failure, renal failure and hepatic failure etc. 3. massive ascites or pleural effusion 4. severe watery diarrhea 5. schronous double cancer 6. pregnancy or lactation 7. physician concludes that the patient's participation in this trial is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of the patients who completed the treatment
- Secondary Outcome Measures
Name Time Method The proportion of adverse events, DFS, and OS.